http://archive.fast-edgar.com/20261102/AILZE22CZ222S9Z2222B2ZZZ56UQZOS2IE82
Filed on: November 2, 2026
http://archive.fast-edgar.com/20261102/ACZZM22CL222R2Z2222922ZZK3GSZ2USAE82
Filed on: November 2, 2026
http://archive.fast-edgar.com/20261102/AF22A22GZZ2RLTZ2229W2ZYOGNLEYZ22N282
Filed on: November 2, 2026
As filed with the Securities and Exchange Commission on November 2, 2026.
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
PASQAL HOLDING SA
(Exact name of registrant as specified in its charter)
France Not applicable
(State or other jurisdiction of
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
F O R M 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2026
Commission file number: 0-16050
TAT TECHNOLOGIES LTD.
(Name of Registrant)
9335 Harris Corners Pkwy, Charlotte, NC 28269
(Address of Principal Executive Office)
Indicate by check mark whether... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K uniQure N.V. For: Oct 30
-
Form 8-K INOVIO PHARMACEUTICALS, For: Oct 30
-
Form 8-K Flowco Holdings Inc. For: Nov 02
-
Form 6-K EMBRAER S.A. For: Dec 31
-
Form 8-K Lumentum Holdings Inc. For: Nov 02
-
Form 10-Q Boardwalk Pipeline Partn For: Sep 30
-
Form 6-K Fort Technology Inc For: Nov 02
-
Form 6-K ParaZero Technologies For: Nov 02
-
Form 10-Q Seaport Therapeutics, For: Sep 30
-
Form 425 Graf Global Corp. Filed by: Graf Global Corp.
-
Form 8-K Krystal Biotech, Inc. For: Nov 02
-
Form 425 Graf Global Corp. Filed by: Graf Global Corp.
-
Form 6-K Shell plc For: Nov 02
-
Form 8-K Axsome Therapeutics, For: Nov 02
-
Form 6-K TAT TECHNOLOGIES LTD For: Nov 02
-
Form 10-Q Krystal Biotech, Inc. For: Sep 30
-
Form 8-K TripAdvisor, Inc. For: Nov 01
-
Form 6-K DIAGEO PLC For: Nov 02
-
Form 6-K RedHill Biopharma Ltd. For: Nov 02
-
Form 10-Q Tempus AI, Inc. For: Sep 30
-
Form 8-K Seaport Therapeutics, For: Nov 02
-
Form 6-K Can-Fite BioPharma Ltd. For: Nov 02
-
Form 6-K TAT TECHNOLOGIES LTD For: Sep 30
-
Form 8-K Vertical Data Inc. For: Nov 02
-
Form 424B2 MICROSOFT CORP
-
Form 8-K Information Services For: Nov 02
-
Form 8-K MARRIOTT INTERNATIONAL For: Nov 02
-
Form 8-K Eton Pharmaceuticals, For: Nov 02
-
Form 1-U Naqi Logix Inc. For: Nov 02
-
Form 8-K Tempus AI, Inc. For: Nov 02
-
Form 6-K KAMADA LTD For: Nov 02
-
Form 6-K Tiziana Life Sciences For: Nov 02
-
Form 8-K Alpine Income Property For: Oct 30
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 8-K ACCENDRA HEALTH INC/VA/ For: Oct 29
-
Form S-6 m funds Trust
-
Form 6-K XPENG INC. For: Nov 02
-
Form 4 Nebius Group N.V. For: Oct 29 Filed by: Boynton John Wilson IV
-
Form 424B2 CITIGROUP INC
-
Form 8-K Atrium Therapeutics, For: Nov 02
-
Form 6-K BARCLAYS PLC For: Nov 02
-
Form 8-K Kosmos Energy Ltd. For: Oct 30
-
Form 10-Q Sinda Ltd. For: Sep 30
-
Form 6-K Perion Network Ltd. For: Nov 02
-
Form 8-K U.S. GoldMining Inc. For: Nov 02
-
Form 485BXT GraniteShares ETF Trust
-
Form 485BXT GraniteShares ETF Trust
-
Form 485BXT GraniteShares ETF Trust
-
Form 485BXT GraniteShares ETF Trust
